Robot 'Pancreas' tested in tiny diabetes study

NCT ID NCT05386849

Completed Disease control Sponsor: Ideal Medical Technologies Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small safety study tested a new artificial intelligence system called FUSION that automatically controls blood sugar levels in people with type 2 diabetes. Three participants who use insulin at home had their glucose managed by the device for 24 hours while eating standard meals. The main goal was to see how often blood sugar stayed in a safe range and how often it dropped too low.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FUSION closed loop glucose control system (a device that uses artificial intelligence to automatically adjust insulin and keep blood sugar in a target range)
What this could lead to: If successful, this could lead to a device that automatically manages blood sugar for type 2 diabetes patients, reducing the need for manual insulin adjustments.
What could go wrong: This was a very small, early safety study with only 3 participants. The device is designed for hospital use, not daily life, and may not work for all patients. More research is needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

Emory University

Atlanta, Georgia, 30322, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.